Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy

Daniel Medina; Kevin David; Yong Lin; Dale Schaar; Vimal Patel; Mecide Gharibo; Rajat Bannerji; Kelly Walton; Joseph Aisner; Arnold B Rabson; Roger Strair

doi:10.1080/10428194.2016.1225206

Back

Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy

Journal article

Peer reviewed

Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy

Daniel Medina, Kevin David, Yong Lin, Dale Schaar, Vimal Patel, Mecide Gharibo, Rajat Bannerji, Kelly Walton, Joseph Aisner, Arnold B Rabson, …

Leukemia & lymphoma, Vol.58(5), pp.1227-1230

05/2017

DOI: https://doi.org/10.1080/10428194.2016.1225206

PMID: 27659510

Abstract

Signal Transduction

Humans

Leukemia, Myeloid, Acute - metabolism

Antineoplastic Combined Chemotherapy Protocols - adverse effects

Gene Expression Regulation, Leukemic - drug effects

NF-kappa B - metabolism

Treatment Outcome

Antineoplastic Agents - therapeutic use

Gene Expression Profiling

Salicylates - therapeutic use

Choline - therapeutic use

Salicylates - pharmacology

Leukemia, Myeloid, Acute - diagnosis

Antineoplastic Combined Chemotherapy Protocols - therapeutic use

Choline - analogs & derivatives

Choline - pharmacology

Leukemia, Myeloid, Acute - drug therapy

Antineoplastic Agents - pharmacology

Leukemia, Myeloid, Acute - genetics

Metrics

14 Record Views

4 Times Cited - Web of Science

Details

Title: Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy
Creators: Daniel Medina - a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey , NJ , USA
Kevin David - a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey , NJ , USA
Yong Lin - b Department of Biostatistics , Rutgers Biomedical and Health Sciences , Piscataway , NJ , USA
Dale Schaar - a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey , NJ , USA
Vimal Patel - a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey , NJ , USA
Mecide Gharibo - a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey , NJ , USA
Rajat Bannerji - a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey , NJ , USA
Kelly Walton - a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey , NJ , USA
Joseph Aisner - a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey , NJ , USA
Arnold B Rabson - c Child Health Institute , Robert Wood Johnson Medical School, Rutgers the State University of New Jersey , NJ , USA
Roger Strair - a Division of Medical Oncology , Rutgers Cancer Institute of New Jersey, Rutgers the State University of New Jersey , NJ , USA
Publication Details: Leukemia & lymphoma, Vol.58(5), pp.1227-1230
Date published: 05/2017
Academic Unit: Immunology Oncology; Biostatistics (SHP); Child Health Institute of New Jersey; Hematologic Malignancies Program; Blood and Marrow Transplant Program; Lung Cancer/Thoracic Oncology Program
Language: English
Resource Type: Journal article
Identifiers: 991031654642804646